-
Mount injury overshadows Man Utd draw with Paris Saint-Germain
-
All Black Tuipulotu surprised after Sharks include Nonu
-
Ukraine denies targeting Bulgaria as drone explodes near pipeline
-
Infantino denies allegations of affair, favouritism while at UEFA: report
-
Vollering grabs Tour de France lead in Nice
-
MotoGP leader Martin soars to victory in British GP sprint race
-
Euros to showcase new TV guidelines on non-sexualisation of women athletes
-
Mosimane set to succeed Broos as South Africa coach
-
'Calm' Kiss savours first win as Wallabies boss
-
Drone enters Bulgaria, explodes near pipeline at Romanian border
-
Duplantis bids for fourth European title as stars align in Birmingham
-
Paris orders e-scooter users to wear helmets, reflective gear
-
Ukraine warns of tough winter as Russia strikes kill 4 in Kyiv region
-
Lionel Messi's father Jorge dies aged 68
-
Recovering Marchand to skip medleys at European swim champs
-
Johnson reveals 'stress' of Grand Slam Track collapse, clarifies payment
-
MotoGP leader Martin speeds to British Grand Prix pole
-
Defending champion Ferrand-Prevot out of Tour de France Femmes
-
Drone enters Bulgaria, explodes near pipeline at Romanian border: Bulgarian PM
-
Wallabies squeeze past Japan to give Kiss a winning start
-
Arsenal sign Brazil midfielder Guimaraes from Newcastle
-
Kyiv mourns recovery volunteer, whose life 'intertwined with the fallen'
-
Atletico will not sell Alvarez, says Simeone
-
Only two vehicles earn perfect child-seat scores for 2026
-
Ford Fathom turns affordable electric pickup into reality
-
Chinese car brands reshape Australia’s automotive market
-
Lise Klaveness, the Norwegian thorn in Infantino's side
-
Electric cars enter their most decisive generation yet
-
Europe’s electric car boom exposes a widening market divide
-
Three Chinese carmakers enter the global automotive top 10
-
US Senate confirms Trump's ex lawyer as attorney general
-
Ukraine's Zelensky visits Russian ally Serbia as Moscow pounds Kyiv
-
Tibet conference in Nepal pushed online
-
Ukraine's Zelensky visits Russian ally Serbia for talks
-
Nocturnal 'coffee frog' discovered in Costa Rica
-
Defending champion Shelton storms to Montreal win
-
India's 'cockroach' protest movement keeps heat on Modi
-
Exodus: West Bank hardships drive out Palestinian Christians
-
Russia's only anti-war party eyes support boost at elections
-
Travis Head wins Australian cricketer of the year gong
-
Canada tries to adapt to a future of wildfires
-
Colombia's new president vows to 'defeat narco-terrorists'
-
Death of NBA forward Clarke ruled accident due to heroin, cocaine
-
Call for Infantino to resign comes amid wave of support
-
Abelardo de la Espriella, Colombian president and flamboyant millionaire
-
Trump ally Abelardo de la Espriella sworn in as Colombia president
-
Maradona's 'Hand of God' ball heads to US auction
-
FIFA chief Infantino gets backing of South American football
-
Rybakina advances while Andreeva exits at Toronto
-
Amazon behind massive private gas plant for new data centers
US Supreme Court to weigh in on abortion pill access
The US Supreme Court was poised to wade into the divisive battle over the abortion drug mifepristone with a ruling due Friday on lower court-ordered restrictions on the widely used pill.
The nation's highest court has until midnight Eastern Time Friday (0400 GMT Saturday) to decide how it will handle the most significant abortion case since it tossed out the constitutional right to the procedure last year.
The conservative-dominated bench had been scheduled to issue a ruling by Wednesday -- but it extended a stay freezing the lower court decisions for two days as it decides what to do next.
The court can rule in any number of ways, and abortion rights and anti-abortion activists -- as well as millions of Americans -- are on tenterhooks waiting to seehow it proceeds.
The case stems from a ruling by a US District Court judge in Texas that would have banned mifepristone, which was approved by the Food and Drug Administration in 2000 and accounts for more than half of all abortions in the United States.
An appeals court blocked a ban on the pill, but imposed tough restrictions on access, after which the baton was handed to the Supreme Court, where conservatives wield a 6-3 majority.
The Supreme Court could further freeze the lower court rulings pending an appeal from the Justice Department and mifepristone manufacturer Danco Laboratories.
It could also allow the rulings restricting access to the abortion pill to take effect while the appeals play out.
The court could also decide to hear arguments in the case itself on an expedited basis.
Complicating the case even further is a ruling by a separate federal court in Washington state that said access to mifepristone should be maintained.
Since the Supreme Court overturned the landmark Roe v. Wade ruling that enshrined the constitutional right to abortion for half a century, 13 states have banned abortion and it has been severely restricted in others.
- 'Deeply misguided' -
Opposition to the legal assault on the abortion pill is being spearheaded by the Justice Department, which argued that the initial federal judge's ruling was based on a "deeply misguided assessment" of the pill's safety.
Mifepristone is one component of a two-drug regimen that can be used through the first 10 weeks of pregnancy.
It has a long safety record, and the FDA estimates 5.6 million Americans have used it to terminate pregnancies since it was approved.
The appellate court, while striking down the ban on mifepristone, restricted its use to seven weeks of pregnancy, down from 10, and prohibited distribution by mail.
In a filing to the court on Tuesday, the anti-abortion coalition that first brought the case against the FDA repeated their controversial claims that the drug was unsafe.
The coalition said the FDA and distributor of mifepristone had "brazenly flouted the law and applicable regulations ... and continually placed politics above women's health."
Polls repeatedly show a clear majority of Americans support continued access to safe abortion, even as conservative groups push to limit the procedure -- or ban it outright.
A.AlHaj--SF-PST